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Introduction
Staphylococcus aureus is one of the most frequently 
isolated pathogens from the hospital or community-
acquired infections. Staphylococci are a large group of 
bacteria in every environment; however, these bacte-
ria can proliferate only in humans or animals. Many 
staphylococcal species colonize the skin and mucosal 
membranes, especially the perineum and pharynx. The 
other sites that harbor these bacteria are the gastrointes-
tinal tract, vagina, and axilla, but carriage in those areas 
is less frequent (Kosecka-Strojek et al. 2018). Tradition-
ally, staphylococci have been divided into two groups 
based on the production of extracellular enzyme coagu-
lase: coagulase-positive staphylococci (CoPS) and coag-
ulase-negative staphylococci (CoNS). The first group 
is represented by well-known opportunistic pathogens 
such as Staphylococcus aureus, Staphylo coccus schleiferi, 
Sta phy lococcus intermedius, and Staphylococcus pseud-
intermedius, and the second group traditionally includes 
nonpathogenic or opportunistic pathogens; however, 
recently, several clinical reports have presented CoNS 
as dangerous pathogens, particularly for newborns or 
immunocompromised patients (Heilmann et al. 2019). 
A few species, namely Staphylococcus hyicus, Staphylo-
coccus agnetis, and Staphylococcus felis, belong to the 
third group – coagulase-variable staphylococci. These 
species are usually grouped with CoPS but cannot 
produce clumping factors, and coagulase production 
tests give variable results (Becker et al. 2014). As oppor-
tunistic pathogens, staphylococci exhibit saprophytic 
characteristics under physiological conditions, but the 
bacteria become severe pathogens under additional 
infection-facilitating conditions.
Staphylococci are etiological agents of diseases 
with various localizations, manifestations and/or 
courses of infection. The most frequent infections are 
local infections, and the bacteria can cause lesions in 
various anatomical tissues. Overall, the infections are 
grouped into skin and soft tissue infections (SSTIs) with 
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A b s t r a c t
Staphylococci are among the most frequent human microbiota components associated with the high level of bloodstream infection (BSI) 
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methods and research etiological factors using advanced genetic methods.
K e y w o r d s: bacteremia, carriage, infection, sepsis, Staphylococcus
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by Exeley Inc.
Lisowska-Łysiak K. et al. 114
manifestations such as dermatitis, abscesses, furuncu-
losis, boils, folliculitis, impetigo, or mastitis, and also 
includes other severe diseases such as staphylococcal 
foodborne disease, toxic shock syndrome, and staphy-
lococcal scalded skin syndrome (SSSS) (Foster 2012; 
Tong et al. 2015). Staphylococci are also common path-
ogens of deep tissue infections, including foreign bodies 
infection. Most studies focused on S. aureus infections, 
but there is strong evidence of the CoNS involvement in 
severe diseases. Osteomyelitis, otitis, wound infection, 
endophthalmitis, urinary tract infection, meningitis, 
or even pneumonia may be caused by S. epidermidis, 
Staphylococcus saprophyticus, Staphylococcus lugdun-
ensis, and S. schleiferi (von Eiff et al. 2002; Becker et al. 
2014; Argemi et al. 2019). When staphylococci gain 
entry into the bloodstream, colonization becomes sys-
temic as bacteremia and then advances to infection.
The literature was screened based on a PubMed 
search using the terms „staphylococci”, „Staphylococ-
cus” and „bloodstream infections” and/or „sepsis”. The 
publications were then evaluated based on a citation 
index. Specific criteria were used to describe the world-
wide occurrence of S. aureus, and CoNS bloodstream 
infections and/or sepsis, such as: only original articles 
were included; the data from different geographical 
regions/countries were analyzed; the articles with the 
highest number of participants and bacterial strains iso-
lated, and those containing long-term studies or the 
recent data, were selected to the analysis.
Bacteremia, bloodstream infection, and sepsis
Bacteremia. Bacteremia is characterized by the 
presence of pathogens in the blood (Pai et al. 2015). 
Transient bacteremia is limited to one or two days, 
without any manifestations, and may be caused by some 
staphylococcal species. Furthermore, the phenomenon 
does not indicate any further manifestation in healthy 
hosts (Samet et al. 2006). The presence of bacteria in the 
blood is eliminated by immunological defense systems 
and is known in the literature as „natural bacteremia” 
or „physiological bacteremia”.
Bloodstream infection. However, in predisposed 
hosts, bacteremia advances to bloodstream infection 
(BSI), manifesting as an inflammatory response against 
microorganisms or/and against their metabolites pre-
sent in the body (Dayan et al. 2016). The BSI can be 
successfully treated or advances to sepsis (Thomer et al. 
2016; Michalik et al. 2020). Sepsis is related to organ dys-
function, perfusion disturbances, or hypotension with 
accompanying lacticaemia, oliguria, and/or psycho lo- 
gical disorders (Samet et al. 2006; Hotchkiss et al. 2016).
Therefore, some S. aureus bacteremia complications, 
such as endocarditis, attributable mortality, embolic 
stroke, or recurrent infection during the 12-week fol-
low-up period, are circumstances associated with the 
increased sepsis frequency from 11% to 43%. When 
the inflammatory response is triggered by the mas-
sive release of pro-inflammatory Th1 cytokines, such 
as TNF-α, IL-1β, IL-6, and IFN-γ, a septic shock may 
occur (Dayan et al. 2016).
Sepsis. Sepsis is the incorrect, inflammatory res-
ponse of the host organism to infection, and often, it is 
a result of systemic bloodstream infections. Recently, 
sepsis is defined as life-threatening organ dysfunc- 
tion caused by a dysregulated host response to infec-
tion (Singer et al. 2016). Untreated sepsis can lead to 
severe sepsis or septic shock and, consequently, mul-
tiple organ failure (Sequential Organ Failure Assess-
ment, SOFA) and death (Stevenson et al. 2016). Sepsis 
is a critical clinical stage of general toxemia and organ 
dysfunction, and a patient’s inflammatory response 
interferes with the functioning of vital organs, such 
as the heart, kidneys, lungs, or liver. Sepsis-3 recom-
mends a new sepsis scoring system, rapid sequential 
assessment of organ failure (qSOFA), consisting of 
3  elements: an altered mental state, respiratory rate, 
and systolic blood pressure (Minejima et al. 2019). 
Patients with suspected infection expected to have 
a prolonged ICU stay can be identified at the bedside 
with quick SOFA, i.e., alteration in mental status, sys-
tolic blood pressure ≤ 100 mmHg, or respiratory rate 
≥ 22/min. Moreover, patients with septic shock can be 
identified with a clinical construct of sepsis with per-
sisting hypotension requiring vasopressors to main-
tain MAP ≥ 65 mmHg and having a serum lactate level 
> 2 mmol/l (18 mg/dl) despite adequate volume resus-
citation (Singer et al. 2016).
Pathogenicity
of staphylococcal bloodstream infections
Antibiotic resistance. Staphylococci exhibit a wide 
resistance to antibiotics. One of the most dangerous fea-
tures of staphylococci is their multi-resistance. Research 
indicates that both the CoPS and CoNS species have 
staphylococcal chromosome cassettes mec (SCCmec) 
that determine resistance to methicillin in both groups. 
Furthermore, the SCCmec elements of CoNS pre- 
sent extreme diversity, which causes many diagnostic 
problems (Hosseinkhani et al. 2018). The increase of 
methicillin-resistant S. aureus (MRSA) isolates in hos-
pital and the community due to horizontal gene transfer 
across bacterial species occurred. The environmental 
and animal-associated CoNS may be underestimated 
factor for the spread of the resistance genes into more 
pathogenic species like S. aureus (Kosecka-Strojek et al. 
2016; Lisowska-Łysiak et al. 2019). Methicillin and 
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vancomycin resistance remain the major antimicrobial 
resistance phenotype of concern. Although still rela-
tively infrequent, multi-resistant CoNS with reduced 
susceptibility to glycopeptides are emerging patho-
gens of clinical concern and should be kept in mind 
in empirical and rational therapy of BSI (Veach et al. 
1990; Natoli et al. 2009). In recent years an emerging 
spread of linezolid-resistant Staphylococcus capitis and 
S. epidermidis strains in Europe was shown (Tevell et al. 
2017; Kosecka-Strojek et al. 2020). An increased resist-
ance is the result of antibiotic pressure, which could 
select resistant clones among staphylococci.
Virulence determinants and other invasion/eva-
sion determinants. Staphylococci exhibit a  strong 
capacity to infect human hosts by using specific strate-
gies to enable the adherence, invasion, persistence, and 
evasion of the host’s immunity mechanisms. However, 
the infection ability is not similar for all species within 
the Staphylococcus genus. In general, CoNS isolates 
present lower levels of virulence determinants than 
CoPS, but the factors involved in colonization support 
invasion in the host (Becker et al. 2014). It is espe-
cially true in extremely immature infants, in whom 
more than 80% of late-onset sepsis (diagnosed after 
72 hours of life) is caused by CoNS (Lauterbach et al. 
2016; Wójkowska-Mach et al. 2019). However, despite 
the relatively low level of virulence, immature infants 
with sepsis caused by these pathogens present a wide 
range of clinical symptoms (Lauterbach et al. 2016). 
It was shown that S. lugdunensis was responsible for 
sepsis and endocarditis on the 1st day of life in a term 
newborn, which underwent lotus birth (Ittleman and 
Szabo 2018). In contrast, S. aureus strains often exhibit 
a vast arsenal of toxins and enzymes involved in staph-
ylococcal pathogenesis. Toxins can lead to a  weak 
response of the human organism because they can 
degrade certain host cells, manipulate the innate and 
adaptive immune response, and degrade intercellular 
junctions, contributing to the S. aureus proliferation 
(Oliveira et al. 2018).
Toxins. One of S. aureus toxicity mechanisms is 
damage to host cell membranes caused by hemolysins, 
bicomponent leukocidins, or phenol-soluble modu-
lins (Herrera et al. 2016). However, it has been proven 
that CoNS also secrete toxins and enzymes. Based on 
CoNS strains whole-genome sequencing (WGS) per-
formed by Argemi et al. (2019), the presence of pro-
teases, lipases, and hemolysins genes in S. epidermidis, 
S. capitis, and Staphylococcus caprae was shown. Moreo-
ver, enterotoxin genes in S. epidermidis and Staphylococ-
cus haemolyticus genomes were shown (Nanoukon et al. 
2018; Argemi et al. 2019). Other toxins produced by 
S. aureus are usually infection-specific, such as entero-
toxins or toxic shock syndrome toxin. Furthermore, 
bacteria-host interactions depend on extracellular 
enzymes, and the largest group of enzymes includes 
proteases. This category consists of serine proteases, the 
metalloprotease aureolysin, and staphopains that are 
engaged in the evasion of complement-mediated kill-
ing, host tissue destruction, immunoglobulin degrada-
tion, and deregulation of fibrinolysis (Miedzobrodzki 
et  al. 2002; Sabat et  al. 2008; Kalińska et  al. 2012; 
Martínez-Garcia et al. 2018).
Biofilm formation. Biofilm formation is an addi-
tional factor associated with CoPS and CoNS infections 
(Grzebyk et al. 2013; Argemi et al. 2019). Biofilm for-
mation is one of the staphylococcal survival strategies 
within host organisms. The presence of staphylococcal 
biofilms is a key factor involved in bacterial resistance 
to various groups of antibiotics. Bacterial biofilms are 
defined as communities of bacterial colonies attached 
to the host surface and surrounded by exopolymeric 
matrix substances strictly regulated by numerous pro-
teins engaged in the biofilm life cycle. It was shown that 
biofilms could evade the host immune response, which 
leads to the persistence of staphylococci. Bhattacharya 
et al. (2018) proved that S. aureus biofilms could release 
leukocidins, which affect extracellular trap formation 
and allow evasion of neutrophil-mediated killing. Bio-
film production has also been proven for CoNS spe-
cies, including S. lugdunensis that produces adhesins 
and other biofilm promoters (Argemi et al. 2017). 
Staphylococcal pathogenesis is a process that involves 
an array of extracellular proteins, biofilm, and cell wall 
components that are coordinately expressed in different 
phases of infection. The expression or suppression of 
two divergent loci, accessory gene regulator (agr) and 
staphylococcal accessory regulator (sar) are recogni- 
zed as critical regulators of virulence in staphylococci 
(Arya and Princy 2013).
Risk factors present in humans: predisposed 
patients. Several studies have shown that host risk 
factors may significantly enhance the effects of BSIs, 
including mortality. The high-risk group of staphylo-
coccal infections contains mostly patients with indwell-
ing medical devices. The highly predisposed groups 
also contain premature newborns or elderly patients 
or multimorbid, chronically ill, or immunosuppressed 
patients. A large group of the patients infected is also 
those with inserted foreign plastic bodies, such as 
implants and venflons.
The essential patients’ factors that determine blood-
stream infections and complications are age, presence 
of comorbidities, and appropriate initial antibiotic 
treatment (Ayau et al. 2017). Bloodstream infections 
occur in elderly patients over 75 years old, resulting in 
increased mortality (Gasch et al. 2013). A 9-year study 
performed by Ayau et al. (2017) underlined risk fac-
tors that increased the probability of mortality, such as 
age, cancer, heart disease, neurological disease, nursing 
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home residence, and Charlson score greater than 3. In 
fact, cancer itself increases the 30-day mortality, but 
Bello-Chavolla et al. (2018) reported additional risk 
factors, including hematologic malignancy, hypergly-
cemia, abdominal source of infection, and endocarditis, 
based on studies conducted on patients with cancer. 
Malignancy was also confirmed to be a key factor asso-
ciated with poor outcomes of infection in other studies 
(Papadimitriou-Olivgeris et al. 2019).
Epidemiology: Worldwide distribution
of staphylococcal bloodstream infections
Staphylococcal bloodstream infections are cur-
rently a challenging issue for clinicians, diagnosticians, 
and microbiologists, primarily due to their high fre-
quency worldwide. Studies on bloodstream infection 
episodes differ slightly from each other because of the 
high number of patients and the number of institu-
tions involved in providing the data. Interestingly, all 
of these studies confirmed a high number of staphylo-
cocci isolated from blood samples, ranging from 23.9 to 
79.2% (Table I). In many cases, S. aureus, usually MRSA 
isolates, and CoNS were the predominant species 
involved in BSI episodes. However, most importantly, 
staphylococcal bloodstream infections affect the whole 
world, not only developing countries. It is imperative 
to analyze the data to implement standard diagnostic 
methods, to compare the results among various coun-
tries, to evaluate existing preventive measures, and to 
plan effective infection prevention and control pro-
grams or establish new programs, including the use of 
advanced genetic methods (Dik et al. 2016; Sabat et al. 
2017; Kosecka-Strojek et al. 2019). This study compares 
staphylococcal bloodstream infections in the world. The 
evaluation of S. aureus and CoNS as etiological agents 
of BSI of the cited publications was made under the 
following criteria: the studies included patients with 
symptoms of BSI/sepsis; pathogens grew on at least one 
percutaneous blood culture and a culture of the catheter 
tip; bacteria have been identified as S. aureus or CoNS 
species using commercial/automated identification 
tests; susceptibility testing was performed, and CoNS 
species from positive blood samples were included in 
comprehensive data for analysis except where specified 
in the laboratory records as contaminants.
Europe. The epidemiology of BSI episodes in Europe 
was analyzed in detail. The European Centre for Disease 
Prevention and Control (ECDC 2008; 2018) presented 
that CoNS were the most numerous bloodstream infec-
tions pathogens isolated in Europe. Moreover, the big-
gest groups of infected patients consisted of neonates 
and children, and the probability of serious complica-
tions such as long-term adverse neurological outcomes 
or mortality remained high for these infections (Zingg 
et al. 2017). Deptuła et al. (2018) reported that catheter-
related BSI episodes in Poland occurred in 48.9% of 
the patients analyzed, and the predominant pathogens 
were CoNS. These results suggest a strong need for the 
construction of functional incidence-based surveillance 
programs in Poland to reduce BSI episodes. The Neona-
tology Surveillance Network (PNSN) prepared one of 
these programs and focused on late-onset BSI (LO-BSI) 
in very-low-birth-weight infants. The study showed 
that CoNS were the most common cause of LO-BSI 
(Wójkowska-Mach et al. 2014). Both studies confirmed 
that it is necessary to implement a national program for 
infectious disease monitoring and prevention.
Another study in Germany focused on pediatric BSI 
was based on 20 years of sample collection at a tertiary 
care hospital. This study conducted a complex observa-
tion of a large group of BSI episodes. The results showed 
an increasing number of CoNS to be responsible for 
these infections (Hufnagel et al. 2008). Similar results 
were published by Buetti et al. (2017), which were 
based on a 7-year surveillance study in Switzerland, 
although the major pathogen isolated was Escherichia 
coli. These findings were confirmed by other studies 
performed in Switzerland when staphylococci caused 
a  big group of BSI episodes, but the major isolated 
pathogens were Gram-negative rods (Papadimitriou- 
Olivgeris et al. 2019).
On the other hand, an increase in the presence of 
CoNS was observed, but a minority of studies identi-
fied bacteria to the species level. One of these studies 
was performed in Sweden and showed the CoNS were 
related to newborns’ sepsis from 1987 to 2014. The 
authors presented that S. epidermidis (67.4%) was the 
most frequent pathogen, followed by S. haemolyticus 
(10.5%), and S. capitis (9.6%) (Ehlersson et al. 2017). 
The epidemiological study in France was partially 
consistent with previously mentioned research and 
showed that E. coli was the primary pathogen in 36% 
of BSI episodes, followed by S. aureus (16%), and CoNS 
(8%). The other investigation from France showed the 
median rate of CoNS in sepsis (12.2%), and all of these 
strains belonged to S. capitis species (Butin et al. 2017). 
However, studies in the United Kingdom, Greece, 
Netherlands, and Romania confirmed that CoNS were 
predominant pathogens in BSI episodes and sepsis 
(Cailes et al. 2018; Zlatian et al. 2018; Gkentzi et al. 2019; 
Zonnenberg et al. 2019).
Asia. A study designed in Japan by Takeshita et al. 
(2017) showed that the major pathogens isolated from 
BSIs were CoNS (736 cases, 23%), but S. aureus isolates 
were also among the most commonly isolated strains. 
These results were comparable to those observed in 
Europe (Takeshita et al. 2017). The authors also focused 
on 30-day mortality associated with the species and the 
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group of pathogens. They concluded that the highest 
mortality rates were exhibited by hospital-acquired BSI 
(HA-BSI) pathogens, followed by community-onset 
healthcare-associated BSI (CHA-BSI), and the most 
dangerous species were CoNS and Klebsiella pneumo-
niae. The study from South Korea showed that CoNS 
were the most frequent pathogens engaged in neonatal 
sepsis (Lee et al. 2015). Studies in India proved a high 
staphylococci frequency in BSI episodes, however, 
gram-negative rods were mostly isolated in major-
ity from blood samples (Bandyopadhyay et al. 2018). 
On the other hand, CoNS became the major isolated 
pathogen in neonatal sepsis in China, Nepal, Taiwan, 
Turkey and the Arab States, which proves widespread 
staphylococcal-caused sepsis in Asia (Jiang et al. 
2016; Chen et al. 2017; Hammoud et al. 2017; Thapa 
and Sapkota 2019; Mutlu et al. 2020). These findings 
strongly correlate with European data.
North America and South America. In the USA 
research performed by Larru et al. (2016) presented 
similar results as European or Asian studies. The most 
commonly isolated pathogens were CoNS and S. aureus, 
and these pathogens were associated with healthcare-
acquired BSI. Moreover, the authors confirmed that all 
the CoNS were evidenced as pathogens and not as con-
taminants. Another study from the USA showed a sig-
nificant majority of S. aureus strains involved in neo-
nate sepsis (Khare et al. 2020). The predisposed patients’ 
characteristics were also comparable to those observed 
in Europe. These studies showed that the most endan-
gered group consists of children and infants, especially 
with prolonged hospitalization.
Interestingly, children hospitalized since birth 
exhibited a significantly low prevalence of hospital-
onset S. aureus bacteremia (Burke et al. 2009). For 
comparison with the USA, Latin American countries 
were also analyzed for staphylococcal bloodstream 
infections. Arias et al. (2017) presented a paper sum-
marizing the results for nine South American countries, 
from Mexico to Argentina. This study did not evalu-
ate the number of coagulase-negative staphylococci 
but showed many MRSA strains found in BSI samples 
from these countries. Notably, the highest number of 
participants with MRSA-associated BSI was reported 
in Brazil. Other studies confirmed that the preva-
lence of intensive-care unit-acquired infections was 
higher in Brazilian hospitals than in European coun-
tries and in the USA (Braga et al. 2018). On the other 
hand, the highest rates of CoNS (44.3%) were present 
in NEOCOSUR studies on five Latin American coun-
tries: Argentina, Chile, Paraguay, Peru and Uruguay 
(Escalante et al. 2018).
Africa. The World Health Organization (WHO) 
reported that, to date, information regarding blood-
stream infections in Africa is scarce due to the lack of 
research (Bagheri Nejad et al. 2011). However, it was 
estimated that the incidence of bloodstream infections 
(up to 14.8%) in developing countries in Africa was up 
to twice as high as the average European prevalence 
(7.1%) (ECDC 2008). The studies cited were not corre-
lated with each other with respect to the microbiologi-
cal data; the major BSI-associated pathogens presented, 
such as Pseudomonas aeruginosa, E. coli, K. pneumo-
niae, Enterobacter spp., and S. aureus, varied among 
papers (Bagheri Nejad et al. 2011). Besides, the most 
recent investigations showed a significant increase in 
CoNS prevalence in BSI episodes in Africa. Labi et al. 
(2016) showed a high number of positive blood culture 
samples (21.9%) among neonates, and the significant 
pathogens were CoNS. Nanoukon et al. (2017) obtained 
similar results in Benin, where S. haemolyticus and 
S. epidermidis were identified as the most frequently 
isolated pathogens. Similar results were also obtained 
in Egypt and Malawi (Mashaly and El-Mahdy 2017; 
Musicha et al. 2017). CoNS were confirmed as a major 
pathogen isolated in further investigations on smaller 
groups of patients, mostly neonates in Egypt and 
Ethiopia (Seliem and Sultan 2018; Sorsa et al. 2019). In 
contrast, a study from Zambia reports that the most 
frequent pathogen isolated from neonates with sepsis 
was Klebsiella sp. (Kabwe et al. 2016).
Australia. The rate of healthcare-associated BSIs 
in Australia is lower than reported elsewhere in the 
world, which was confirmed by a study in Queensland 
on 23 public hospitals and by research conducted by the 
Victorian Healthcare Associated Infection Surveillance 
System (VICNISS) Coordinating Centre in Victoria 
(Si et al. 2016; Gowda et al. 2017; Worth et al. 2018). 
Papers showed that the most frequently reported patho-
gens responsible for BSI episodes were CoNS, from 18.4 
to 24.2%, and S. aureus, from 15.2 to 16.1%.
The distribution of all of the aforementioned staphy-
lococcal bloodstream infections is presented in Table I.
S. aureus is one of the most frequent
bloodstream infection agents
According to the ECDC report, S. aureus is one 
of the major agents causing bloodstream infections in 
Europe. Based on the studies conducted in 25 European 
countries, the ECDC estimated the dynamic changes 
in S. aureus clones associated with BSI episodes. The 
report states that the S. aureus BSI infection mortality 
rate was 19.4% of the episodes’ total number. Moreover, 
as expected, the MRSA all-cause mortality (24.4%) was 
higher than that of MSSA infections (17.1%).
Spa types related to S. aureus from BSI in Europe. 
ECDC also estimated 20 of the most frequent MRSA 
and MSSA spa types. The first group included the 
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5 most frequent spa types, namely, t032 (ST22, 17.9%), 
t003 (ST225, 8.8%), t008 (ST8, 8.4%), t002 (ST5, 7.7%), 
and t067 (ST125, 4.4%). Interestingly, the significant 
increase in incidence was related to the multilocus vari-
able number of tandem repeats analysis type (MLVA 
type) ST22, and this lineage constituted 36% of the 
top-ranking isolates in 2011. This MRSA clone was 
first identified in England and was further detected in 
Ireland, Germany, Hungary, Portugal, and Northern 
Italy. The fifth most abundant spa type t067 was firstly 
described in Spain (Grundmann et al. 2014). In com-
parison, the rates of MSSA spa-type frequency were 
lower than those of MRSA isolates, and the 7 most 
popular types were t091 (ST7, 5.3%), t084 (ST15, 4.7%), 
t002 (ST5, 4.6%), t015 (ST45, 3.7%), t008 (ST8, 3.7%), 
t012 (ST30, 3.4%), and t0127 (ST1, 3.2%) (Grundmann 
et al. 2014). Two spa types (t008 and t002) were pre-
sent in both MRSA and MSSA infections, which was 
probably a result of the high overall global frequency 
of these types, according to Ridom SpaServer (www.
spaserver.ridom.de).
Spa types related to S. aureus from BSI in Poland. 
S. aureus, a key pathogen in BSI episodes, was also iden-
tified in a study conducted by our group (Ilczyszyn et al. 
2016). This study, performed on neonates and children 
in Poland, showed the most frequent MRSA geno- 
type to be spa type t003-CC5, which is consistent with 
the data presented by ECDC. Among MSSA strains, 
the most frequent genotypes belonged to the follow-
ing spa types: t091-CC7, t037-CC30, t008-CC8, and 
t240-CC10. Additionally, some of the observed geno-
types exhibited age-related patterns, and the spa type 
t003, spa-CC 002, and CC5 were strongly associated 
with invasive infections in infants and young children 
(Ilczyszyn et al. 2016).
Spa types related to S. aureus from BSI outside 
Europe. A study in China, performed for five years, 
examined S. aureus BSI samples and identified the 
most frequent S. aureus spa types and virulence fac-
tors. According to these data, the most frequent MRSA 
spa type in China was t030/t037, belonging to MLVA 
type ST239. These isolates also harbored SCCmec  III 
cassette, which represents the hospital-acquired strains, 
and an agr system I. In comparison, the most frequent 
Chinese MSSA isolates presented the t318 type ST188 
and also harbored agr I (Liu et al. 2018).
Latin American research divided the most numer-
ous MRSA strains into three clades (A, B, and C) based 
on phylogenetic reconstruction. Strains in clade  A 
belonged to ST5, ST105, and ST1011, and a majority of 
these strains harbored the gene cassette SCCmec I or II 
(HA-MRSA). Clade B consisted of the MLS types 
ST8, ST88, ST97, and ST72, accompanied by SCCmec 
IV variants. The last clade included Argentinian strains 
belonging to ST30 (Arias et al. 2017).
Non-S. aureus staphylococci as bloodstream
infection agents
Human skin is colonized by various staphylococcal 
species, although the most invasive is S. aureus, followed 
by Staphylococcus auricularis, S. capitis, S. epidermidis, 
S. haemolyticus, Staphylococcus hominis, S. saprophyti-
cus, Staphylococcus simulans and Staphylococcus warneri 
(Yu et al. 2017). The CoNS are among the most com-
monly isolated microorganisms from blood samples. 
Compared to S. aureus strains, which are classified as 
invasive pathogens, the clinical significance of CoNS 
needs to be proven. It is essential to estimate whether 
the presence of CoNS represents true bacteremia or 
sample contamination. Many of the studies conducted 
have not estimated the real impact of CoNS associated 
with blood infections, mainly because these species are 
less frequent overall; have not identified these bacteria 
at the species level; or have not distinguished the spe-
cies’ differences. However, several studies have shown 
that CoNS can cause serious bloodstream infections 
(Grzebyk et al. 2013; Li et al. 2016; Szczuka et al. 2016). 
Therefore, host-specific capabilities and strain-spe-
cific features need to be reconsidered for an improved 
understanding of the course of every particular infec-
tion, as under favorable conditions, CoNS species may 
become highly pathogenic (Becker et al. 2014).
CoNS as BSI agents in Europe. A study performed 
in Belgium showed that most isolated bloodstream 
infection-associated CoNS strains belonged to S. epi-
dermidis, and 77% of these strains were identified as 
methicillin-resistant S. epidermidis (MRSE). All of these 
strains presented resistance to a wide range of antibiot-
ics, especially erythromycin (ermA, ermC, and msrA), 
aminoglycosides (aacA-aphD and aadC), tetracycline 
(tetK), and mupirocin (mupA). Molecular typing of 
these strains assigned 85% of the MRSE strains to clonal 
complex (CC) 2, consisting of the ST2, ST5, ST59, 
and ST88 MLVA types (Deplano et al. 2016). Another 
study on S. warneri strains from Poland showed their 
wide range of pathogenicity factors. These strains were 
able to adhere to host cells, produce biofilms, invade 
and destroy epithelial cells, which strongly facilitated 
bacterial persistence (Szczuka et al. 2016). This find-
ing warrants reconsideration of the role of CoNS in 
bloodstream infections.
CoNS as BSI agents in the USA. In studies con-
ducted in the USA, many CoNS isolates (n = 602) were 
found in blood samples from years 2013–2014. The most 
frequently isolated strains belonged to S. epidermidis, 
S. lugdunensis, S. hominis, and S. capitis (Sader et al. 
2016). A high number of blood samples was also ana-
lyzed in Japan by Yamada et al. (2017), and 314 methi-
cillin-resistant CoNS (MRCoNS) strains were found. 
Among the Japanese strains, the predominant strains 
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belonged to S. epidermidis (78.6%), S. haemolyticus 
(14.3%), and S. capitis subsp. ureolyticus. A high num-
ber of CoNS-associated BSI episodes and increasing 
resistance rate should also be confirmation of the dan-
ger based on the presence and spread of these bacteria.
Conclusions
Staphylococci are among the most frequent path-
ogens causing bloodstream infections, which can 
advance to sepsis and are often observed in patients 
with indwelling medical devices or neonates. A high 
number of S. aureus and CoNS-related BSI episodes in 
high-risk patients had evidenced a significant challenge 
for clinicians. Many institutions widely document BSI 
episodes, and there has not been a worldwide decrease 
in these episodes. It is vital to improve existing pre-
vention and control programs based on analysis of the 
data to implement standard diagnostic methods and 
conduct research on etiological factors, including via 
the usage of advanced genetic methods.
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